Clinical Trials Browser

Terminated × Carboplatin × Dermatologic × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02419495 2025-06-04

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

BreastDermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT01009515 2017-10-18

Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

Phase 2 Terminated

19 enrolled 11 charts

Dermatologic

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT01200342 2016-02-11

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Phase 2 Terminated

7 enrolled 3 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT00568451 2015-12-30

Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma

Phase 2 Terminated

12 enrolled 9 charts

Dermatologic

Melanoma

Clinical Trials

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma